NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.News, Brian Armstrong, CoinbaseRead More

You might also be interested in reading 5 out of 7 S&P 500 materials stocks beat EPS estimates this week: Earnings Scorecard.